This funding opportunity supports small businesses conducting exploratory clinical trials of investigational agents such as drugs, biologics, surgical therapies, or devices targeting neurological diseases. Projects should align with the NINDS strategic plan and aim to generate data to inform clinical study design. Clinical trials are optional but encouraged under this mechanism.
Eligible applicants are small businesses located in the U.S. Foreign organizations and non-domestic components of U.S. organizations are not eligible. Foreign components as defined by NIH policy may be allowed.
